Curtis Feagin

Curtis Feagin is an accomplished executive in the pharmaceutical industry with extensive experience in sales and management. At Amgen, from June 2019 to November 2023, Curtis Feagin served as Executive Director of Primary Care Sales, leading a team of over 500 employees and overseeing the strategic direction for Repatha and Otezla in the U.S. market. Prior to Amgen, Curtis Feagin worked at Bristol Myers Squibb from March 1993 to June 2019, holding several key positions including Executive Director of National CV Key Accounts and National Sales Director, where responsibilities included developing Territory Business Plans and ensuring compliance with corporate policies. Curtis Feagin’s early career included sales roles and vertical market representation, earning recognition as a Vice President Club award winner in 1994. Curtis Feagin holds a B.S. in Industrial Management from Clemson University, where full-time work was maintained throughout the education period.